Abstract The chemical universe database GDB-13, which enumerates 977 million organic molecules up to 13 atoms of C, N, O, S and Cl following simple chemical stability and synthetic feasibility rules, represents a vast reservoir for new fragments. GDB-13 was classified using the MQN-system discussed in the preceding paper for the analysis of PubChem fragments. Two hundred and fiftyfive subsets of GDB-13 were generated by the combinatorial use of eight restrictive criteria, including fragmentlike (''rule of three'') and scaffold-like (no acyclic carbon atoms) filters. Virtual screening for analogs of 15 commercial drugs of 13 non-hydrogen atoms or less shows that retrieving MQN-neighbors of a query molecule from GDB-13 or its subsets provides on average a 38-fold enrichment in structural analogs (Daylight-type substructure fingerprint Tanimoto T SF [ 0.7), and a 75-fold enrichment in shapesimilar analogs (ROCS TanimotoCombo score [ 1.4). An MQN-searchable version of GDB-13 is provided at www.gdb.unibe.ch.
Introduction
The discovery of innovative chemotypes is one of the key chemical problems in small molecule drug discovery, in particular at the level of fragments, a size range which also includes many drugs [1] [2] [3] [4] [5] [6] [7] [8] . Beyond all fragment-sized molecules that are already known, such as those collected in the public access database PubChem [9] as discussed in the preceding paper in this issue [10] , one might want to consider all molecules that could ever be possibly synthesized. Along these lines, we recently reported the enumeration of all molecules up to a size of 13 non-hydrogen atoms following predefined chemical stability and synthetic feasibility rules, which produced the chemical universe database GDB-13 containing 977 million virtual molecules of C, N, O, S, Cl [11] . This database was an extension of a previous version GDB-11 containing 26.4 million virtual molecules up to 11 non-hydrogen atoms of C, N, O, F [12, 13] , which was shown to provide a useful starting point for designing bioactive synthetic ligands [14] [15] [16] [17] . GDB-13 exceeds the number of known molecules of similar size by several orders of magnitude and represents a vast and mostly unexploited reservoir for innovation [18] .
The meaningful exploration of GDB-13 requires efficient virtual screening tools to identify compounds of biological interest for synthesis and testing. At present however such exploration is limited by the currently available virtual screening methods, which typically process at most a few million structures within resonable computing time. To address this limitation, we recently reported a molecule classification method for large databases called the MQNsystem [19] . This system places organic molecules in a chemical space [18, [20] [21] [22] on the basis of 42 integer value descriptors for structural and topological features, called MQNs (Table 1) . The MQNs can be determined visually from the structural formula by anyone with basic knowledge in organic chemistry, such that MQN-space is readily accessible to non-specialists. The analysis produces meaningful overviews of large molecular databases such as ZINC [23] and PubChem [9] as color-coded maps derived from principal component analysis (PCA) of the MQN data [24] . Furthermore, the MQN-system computes very fast and performs remarkably well in virtual screening as exemplified previously for the enrichment of bioactives from the DUD dataset from the entire PubChem database [24, 25] .
Herein we report the visualisation and an efficient virtual screening approach for the entire GDB-13 database based on the MQN-system. The database was subdivided into 255 subsets defined by the combinatorial use of eight different criteria limiting structural complexity and functional groups. MQN nearest-neighbour searches performed on the entire GDB-13 or on any of its subsets are shown to rapidly identify structural and shape analogs of any query molecule. Structural similarity between two compounds is typically measured by the substructure fingerprint Thus, scoring MQN-nearest neighbors of a query molecule by substructure fingerprint (SF) similarity (measured by the Tanimoto value T SF ) [26] or by shape similarity (measured by the ROCS TanimotoCombo score) [27] as indicators of bioactivity probability shows that MQN-nearest neighbors are strongly enriched in structural analogs and shape-similar analogs of the query molecule. An MQN-searchable version of GDB-13 is provided at www.gdb.unibe.ch, and should greatly facilitate the exploitation of GDB-13 for the identification of new medicinally relevant small molecules for synthesis and testing.
Results and discussion

Visualisation of GDB-13
The 42 MQN-values were obtained for 975,821,779 molecules in GDB-13, resulting in 37,249,813 different MQNcombinations. The most occupied MQN-bin contained 12,589 molecules, while 4,959,920 MQN-bins contained only one molecule (Fig. 1) [19] . Principal component analysis (PCA) was performed to gain an insight into the data structure. PC1 (51%) represented mostly structural rigidity, with strongly positive loadings in cyclic descriptors e.g. cyclic single bonds (csb) and strongly negative loadings in acyclic descriptors e.g. acyclic single bonds (asb). PC2 (12%) reflected H-bonding behaviour and polarity, with strong positive loadings in hydrogen bond acceptors (hba, hbam), and strongly negative loadings in hydrogen bond donors (hbdm) and carbon counts (c) (Fig. 2) . In the (PC1, PC2) plane, GDB-13 appears as a series of overlapping vertically elongated islands, each containing compounds with increasing numbers of rings and ring atoms (Fig. 3 ). Polar molecules with a high proportion of H-bond acceptor atoms occupy the northern portion of the map, while apolar molecules with mostly carbon atoms occupy the south. This layout corresponds to the (PC1, PC3) view obtained in the analysis of the PubChem fragments presented in the preceding paper. Indeed molecular size, which determined PC2 in the PubChem fragment analysis, does not significantly impact variance in GDB-13 because 87% of the database contains molecules of exactly 13 non-hydrogen atoms.
Subsets of GDB-13 GDB-13 is produced from an exhaustive enumeration starting from mathematical graphs [28] using filters removing many unstable and/or synthetically undesirable functional groups [11] , which circumvents some of the limitations of the enumeration algorithms used in computer-aided structure elucidation [29, 30] . Despite of this careful selection of functional groups, the database still contains a large fraction of problematic molecules in the perspective of synthetic and medicinal chemistry [31] . For example, 35% of GDB-13 molecules contain one or more non-aromatic N-N or N-O bond (in an oxime or hydrazone), 29% contain at least one ester, aldehyde, carbonate, sulfate, epoxide or aziridine, 63% contain at least one non-aromatic carbon-carbon double or triple bond, and 54% contain at least one 3-or 4-membered ring.
To facilitate the identification of molecules with the least problematic structural features and the most relevance for drug discovery in GDB-13, subsets A-H were formed by removing non-aromatic cyclic and acyclic heteroatomheteroatom bonds (subsets A and B), problematic functional groups (subset C), non-aromatic cyclic and acyclic CC-unsaturations (subsets D and E), small cycles (subset F). Further restrictions were taken by applying the ''rule of three'' for fragment-likeness (subset G) [32] , and finally excluding acyclic carbon atoms (defined here as scaffoldlikeness, subset H) ( Table 2 ). The combinatorial application of these criteria defined 255 subsets of decreasing size, with the smallest subset ABCDEFGH applying all criteria cumulatively containing 1.47 million structures, which is still 2.4-fold larger than the 619,675 molecules of that size available in public databases (Fig. 4) .
Virtual screening GDB-13 is far too large for applying advanced virtual screening tools such as docking or shape-based analyses, which are too resource intensive to perform on more than a few million structures [33] . Therefore a virtual screening strategy for GDB-13 should start with a first rapid enrichment step. We showed recently that distances between molecules in MQN-space measured by the cityblock distance (CBD MQN ) provide a useful similarity measure for virtual screening [24, 34, 35] . The CBD MQN between two compounds is simply the sum of the 42 absolute values of the differences between MQN-values across the 42 pairs. Ranking PubChem by CBD MQN relative to a reference bioactive compound was shown to strongly enrich other actives for the same target for most of the 40 classes listed in the DUD-dataset [24, 25] . To test if a similar MQN-based enrichment strategy would be applicable for GDB-13, we searched for analogs of 15 known reference bioactive compounds of 12 or 13 nonhydrogen atoms. An MQN-subset of 150,000 structures was assembled containing the 10,000 MQN-nearest neighbors of each of these 15 bioactive compounds in GDB-13. We then used scoring functions to estimate bioactivity probability in place of actual bioactivity measurements because synthesizing and testing any significant fraction of GDB-13 was not a practical option. ) plane for GDB-13. PC1 codes for molecular rigidity and PC2 codes for polarity, see Fig. 2 . The surface is hashed in 1,000 9 700 pixels. Each pixel is colored according to the occupancy or to the average value in that pixel, following the values indicated on the map on the corresponding color. Saturation to grey indicates the standard deviation for that value in the pixel up to ± 1 (rings), ± 2.1 (ring atoms and H-bond acceptors), and ± 2.8 (carbon atoms). The lightness scale (fading to white) encodes the occupancy in a logarithmic scale between 0 (white) and 200 (full color). For the category map molecules were assigned to categories in the priority order heteroaromatic (red) [aromatic (purple, not visible) [fused heterocycles (blue) [fused carbocycles (cyan) [heterocycles (green) [carbocycles (green-yellow) [heteroacyclic compounds (acyclic molecules with interrupted carbon chain, yellow) [carboacyclic compounds (acyclic molecules with continuous carbon chain, orange), and pixels were colored following the most frequent category in that pixel with fading to grey indicating category purity in the pixel GDB molecules were first scored using the Tanimoto similarity coefficient of a 1,024-bit Daylight-type substructure fingerprint (T SF ) [26] . Substructure fingerprints are binary fingerprints in which bits are turned on whenever a particular substructure is present in a molecule, with substructures defined as groups of atoms connected by bonds up to a given maximum topological length, in our case up to 7 bonds. Therefore, the similarity coefficient T SF reflects structural similarity but is strongly correlated with bioactivity because structural analogs often share similar bioactivities. The T SF values of all 977 million GDB-13 molecules to each of the 15 reference bioactive compounds was computed. A threshold value of T SF [ 0.7 was used for hit identification by structural similarity, which gave a hit rate of 0.12% across the entire GDB-13. Similar values were observed in the different subsets A-H (hit rate = 0.14 ± 0.05% across the eight subsets), indicating that substructure limitations had relatively little impact on the hit rate. Interestingly, the MQN-nearest neighbor subset showed a hit rate of 4.5%, indicating that MQN-nearest neighbours were enriched 38-fold for high similarity analogs over the entire database (Table 3) . [32] h excludes acyclic carbon atoms Table 2 b maximum T SF value against the 15 bioactive compounds. T SF is the Tanimoto similarity coefficient for a 1,024-bit Daylight-type substructure fingerprint c containing the 10,000 MQN-nearest neighbors of each of the 15 reference bioactive compounds
In a second approach, GDB-13 and its subsets were scored using the ROCS TanimotoCombo score. The ROCS (Rapid Overlay of Chemical Structures) TanimotoCombo score measures the similarity between 3D shapes of molecules by maximizing an overlap function between molecular shapes, considering these shapes as continuous functions constructed from atom-centered electrostatic and volume Gaussians [27] . The score is maximized by comparing various conformers of both query and reference molecule. This 3D shape-based approach is well-validated for ligand-based virtual screening [36] . ROCS was applied to search for shape-similar compounds of each of the 15 selected bioactive compounds among four different sets: (1) 10,000 randomly selected compounds from GDB-13, or (2) from subset ABCDE (Table 1) , (3) 10,000 MQNnearest neighbors of the respective bioactive compound taken from GDB-13, or (4) from subset ABCDE. For each structure, all possible diastereoisomers were generated and Fig. 5 Gaussian distribution of ROCS scores in ranking various subsets. Green line: 10,000 randomly selected compounds from GDB-13. Blue line: 10,000 randomly selected compounds from subset ABCDE. Black line: 10,000 MQN-nearest neighbors of the respective bioactive compound taken from GDB-13. Red line: 10,000 MQN-nearest neighbors of the respective bioactive compound taken from subset ABCDE the score of the highest scoring stereoisomer was retained. In each case a Gaussian distribution of ROCS scores was observed (Fig. 5) . Strikingly, the MQN-nearest neighbor series (3) and (4) ranked on average 0.29 ± 0.06 units higher than the non-MQN selected series (1) and (2) (Fig. 6 ). On average 22 ± 11% of each MQN-nearest neighbor subset (3) and (4) scored higher than 1.4, which can be considered as an indicator of similar bioactivity [37] . By comparison the random selections (1) and (2) contained only 0.29 ± 0.24% of compounds with ROCS [ 1.4. The MQN-nearest neighbors thus contained 75-fold more high-ROCS compounds than the random selection.
A closer analysis of the T SF and ROCS scores as a function of CBD MQN from the reference drugs showed that MQN-neighbors (CBD MQN B 15) consistently provided many high T SF and high ROCS scoring compounds, while structures at larger MQN-distance (CBD MQN [ 15) had generally low scores (Fig. 7) . The T SF and ROCS scores were however only weakly correlated. The ''high-ROCS, low T SF '' compounds are of particular interest since these represent scaffold-hopping analogs [38] . Examples of analogs with high scores with only one of the similarity measures are shown in Fig. 8 . Note that these examples were taken mostly from subset ABCDE, which excludes in particular non-aromatic CC unsaturations (criteria DE) and thereby avoids compounds with cyclohexadiene and cyclopentadiene analogs of aromatic rings. Such cyclic dienes are indeed highly similar in shape to aromatic rings, but are not advisable as synthetic targets due to their reactivity, in particular towards oxidative aromatization (cyclohexadienes), electrocyclic isomerization or dimerization (cyclopentadienes).
Conclusion
The chemical universe database GDB-13 was analyzed by MQN and subdivided into 255 subsets by the combinatorial use of eight different restrictive criteria eliminating problematic functional groups and structural elements. Virtual screening for analogs of fifteen bioactive compounds of 12 or 13 non-hydrogen atoms showed that selection of MQN-nearest neighbors of any query molecule (using CBD MQN as distance measure) provides subsets that are enriched in high-scoring compounds in terms of both structural similarity (T SF ) and shape similarity (ROCS TanimotoCombo score). The automatic retrieval of MQN-nearest neighbors from GDB-13 or its subsets is facilitated by a search tool available at www.gdb.unibe.ch. The method should greatly facilitate the exploitation of GDB-13 for the identification of new medicinally relevant small molecules for synthesis and testing.
Methods
MQNs
MQNs were calculated using the previously reported calculator source code (Supporting Information in Ref. [19] ) written in Java using the JChem library from Chemaxon, Ltd. Prior to MQN-calculation, the ionization state of each structure was adjusted to pH 7.4 using the JChem API. PCA [39] was done by using an in-house developed Java application using Jsci (http://jsci.sourceforge.net). 
